Dominique Ramirez

402 citations
17 papers · 232 indexed · h-index 9

Dominique Ramirez

17 papers receiving 228 citations

Peers

Dominique Ramirez
Comparison fields: 5 of 86
  • Equine 4
  • Pharmacology 40
  • Small Animals 14
  • Oncology 51
  • Biochemistry 11
Replace S.A.M. Selway with:
S.A.M. Selway United Kingdom
Eriko Muro Japan
Sang‐Mo Kwon South Korea
Leila Reyes Australia
Imane Bara France
D. A. Fitzgerald United Kingdom
Karyn E. O'Connell United States
Holly K. Sheldon United States
Ryohei Yoshitake Japan
Chia-Wen Hsu United States
Dominique Ramirez relative to S.A.M. Selway United Kingdom S.A.M. Selway's profile →
Citations per field
00.5×10×15×20×25×
S.A.M. Selway · 1×
Citations per year

Countries citing papers authored by Dominique Ramirez

Since Specialization
Citations

This map shows the geographic impact of Dominique Ramirez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Ramirez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Ramirez more than expected).

Fields of papers citing papers by Dominique Ramirez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Ramirez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Ramirez. The network helps show where Dominique Ramirez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dominique Ramirez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dominique Ramirez Line = papers co-authored together Dominique Ramirez links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20251
2 202426
3 202415
4 20237
5 20231
6 202324
7 20222
8 202138
9 202023
10 20201
11 202017
12 201912
13 201912
14 20188
15 20186
16 201835
17
Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).
19964

About Dominique Ramirez

Dominique Ramirez is a scholar working on Equine, Transplantation and Pharmacology, having authored 17 papers that have together received 232 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), RNA Research and Splicing (4 papers), Protein Structure and Dynamics (2 papers), Cannabis and Cannabinoid Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Glycosylation and Glycoproteins Research (1 paper), Virus-based gene therapy research (1 paper) and Renal Transplantation Outcomes and Treatments (1 paper). The work is most often cited by research in Equine (4 citations), Pharmacology (40 citations) and Small Animals (14 citations). Dominique Ramirez has collaborated with scholars based in United States, Slovenia and China. Frequent co-authors include Daniel L. Gustafson, Michael R. Shirts, Loren E. Hough, Stephanie McGrath, Luke A. Wittenburg, Steven Dow, Lyndah Chow, Gregor Anderluh, Kristina Eleršič and William H. Wheat. Their work appears in journals such as Nature Communications, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026